EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyperglycemia‐induced Sirt3 downregulation increases microglial aerobic glycolysis and inflammation in diabetic neuropathic pain pathogenesis

Yongchang Li, Erliang Kong, Ruifeng Ding, Ruitong Chu, Jinfang Lu, Mengqiu Deng, Tong Hua, Mei Yang, Haowei Wang, Dashuang Chen, Honghao Song, Huawei Wei und 3 weitere

CNS Neuroscience & Therapeutics · 2024

DOI: 10.1111/cns.14913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Yongchang Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Sirtuin 3, Glycolysis, Down-Regulation, Hyperglycemia. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperglycemia‐induced neuroinflammation significantly contributes to diabetic neuropathic pain (DNP), but the underlying mechanisms remain unclear.

Objective

To investigate the role of Sirt3, a mitochondrial deacetylase, in hyperglycemia‐induced neuroinflammation and DNP and to explore potential therapeutic interventions. Method and Results Here, we found that Sirt3 was downregulated in spinal dorsal horn (SDH) of diabetic mice by RNA‐sequencing, which was further confirmed at the mRNA and protein level. Sirt3 deficiency exacerbated hyperglycemia‐induced neuroinflammation and DNP by enhancing microglial aerobic glycolysis in vivo and in vitro. Overexpression of Sirt3 in microglia alleviated inflammation by reducing aerobic glycolysis. Mechanistically, high‐glucose stimulation activated Akt, which phosphorylates and inactivates FoxO1. The inactivation of FoxO1 diminished the transcription of Sirt3. Besides that, we also found that hyperglycemia induced Sirt3 degradation via the mitophagy‐lysosomal pathway. Blocking Akt activation by GSK69093 or metformin rescued the degradation of Sirt3 protein and transcription inhibition of Sirt3 mRNA, which substantially diminished hyperglycemia‐induced inflammation. Metformin in vivo treatment alleviated neuroinflammation and diabetic neuropathic pain by rescuing hyperglycemia‐induced Sirt3 downregulation.

Conclusion

Hyperglycemia induces metabolic reprogramming and inflammatory activation in microglia through the regulation of Sirt3 transcription and degradation. This novel mechanism identifies Sirt3 as a potential drug target for treating DNP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 3GlycolysisDown-RegulationHyperglycemiaMicrogliaDiabetes Mellitus, ExperimentalMice, Inbred C57BLDiabetic NeuropathiesAnimalsMiceMaleInflammationNeuroinflammatory DiseasesMetformin

Stichwörter der Autor:innen

Akt/FoxO1Sirt3diabetic neuropathic painglycolysismetforminneuroinflammation

Substanzen

Sirtuin 3Sirt3 protein, mouseMetformin

Autor:innen und Institutionen

  • Department of Anesthesiology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
  • Department of Anesthesiology, The 988th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army, Zhengzhou, Henan, China.
  • Department of Neurology, Naval Medical Center of PLA, Naval Medical University, Shanghai, China.
  • Department of Histology and Embryology, Shanghai Key Laboratory of Cell Engineering, Naval Medical University, Shanghai, China.
  • National Key Laboratory of Immunity & Inflammation, Naval Medical University, Shanghai, China.

ORCID-Profile: Hongbin Yuan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, Y., Kong, E., Ding, R., Chu, R., Lu, J., Deng, M., Hua, T., Yang, M., Wang, H., Chen, D., Song, H., Wei, H., Zhang, P., Han, C., & Yuan, H. (2024). Hyperglycemia‐induced Sirt3 downregulation increases microglial aerobic glycolysis and inflammation in diabetic neuropathic pain pathogenesis. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14913

Vancouver

Li Y, Kong E, Ding R, Chu R, Lu J, Deng M, et al. Hyperglycemia‐induced Sirt3 downregulation increases microglial aerobic glycolysis and inflammation in diabetic neuropathic pain pathogenesis. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14913

BibTeX
@article{Li2024,
  author = {Li, Yongchang and Kong, Erliang and Ding, Ruifeng and Chu, Ruitong and Lu, Jinfang and Deng, Mengqiu and Hua, Tong and Yang, Mei and Wang, Haowei and Chen, Dashuang and Song, Honghao and Wei, Huawei and Zhang, Ping and Han, Chaofeng and Yuan, Hongbin},
  title = {Hyperglycemia‐induced Sirt3 downregulation increases microglial aerobic glycolysis and inflammation in diabetic neuropathic pain pathogenesis},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  doi = {10.1111/cns.14913}
}
Kostenlos starten →